Breast Implant Texturization Does Not Affect the Crosstalk Between MSC and ALCL Cells
- 331 Downloads
In the last decade, there has been a growing interest about the possible association between anaplastic large cell lymphoma (ALCL) and breast implants (BIA-ALCL). Many variables, such as breast implants texturization, have been investigated. Breast implants often lead to the formation of a periprosthetic capsule, characterized by inflammation. The presence of the inflamed capsule has been found in the majority of patients with BIA-ALCL. Inflammation may be sustained or counteracted by mesenchymal stem cells (MSCs) by the secretion of pro- or anti-inflammatory cytokines. MSCs were isolated from three capsules surrounding micro-textured (micro-MSCs) and from three capsules surrounding macro-textured (macro-MSCs) implants; after characterization, MSCs were co-cultured with KI-JK cells (a cell line derived from the cutaneous form of ALCL). The secretion of cytokines related to inflammation, the proliferation rate, and the expression of genes referred to pro-tumoral mechanisms were evaluated. Co-cultures of KI-JK cells with micro- or macro-MSCs gave the same results about the secretion of cytokines (increase of IL10, G-CSF, and TGF-β1 and decrease of IL4, IL5, IL12, IL13, IL17A, IFN-γ (p < 0.05) with respect to mock sample), expression of selected genes (increase for ACVR1, VEGF, TGF-βR2, CXCL12, and MKi67 (p < 0.05) with respect to control sample), and the proliferation rate (no variation between mock and co-cultured samples). Our results suggest that MSCs derived from capsules surrounding micro- and macro-textured implants display the same effects on the ALCL cells.
KEY WORDSbreast implants mesenchymal stem cells inflammation texturization ALCL
Compliance with Ethical Standards
This study was approved by the Università Politecnica delle Marche Ethical Commitee and was conducted in accordance with the Declaration of Helsinki.
Conflict of Interest
The authors declare that they have no conflict of interest.
- 1.Ramos-Gallardo, G., J. Cuenca-Pardo, E. Rodríguez-Olivares, R. Iribarren-Moreno, L. Contreras-Bulnes, A. Vallarta-Rodríguez, M. Kalixto-Sanchez, C. Hernández, R. Ceja-Martinez, and C. Torres-Rivero. 2017. Breast implant and anaplastic large cell lymphoma meta-analysis. Journal of Investigative Surgery 30: 56–65.CrossRefGoogle Scholar
- 2.Brody, G.S., D. Deapen, C.R. Taylor, L. Pinter-Brown, S.R. House-Lightner, J.S. Andersen, G. Carlson, M.G. Lechner, and A.L. Epstein. 2015. Anaplastic large cell lymphoma occurring in women with breast implants: Analysis of 173 cases. Plastic and Reconstructive Surgery 135: 695–705.CrossRefGoogle Scholar
- 5.Richardson, K., T. Alrifai, K. Grant-Szymanski, G.J. Kouris, P. Venugopal, B. Mahon, and R. Karmali. 2017. Breast implant-associated anaplastic large-cell lymphoma and the role of brentuximab vedotin (SGN-35) therapy: A case report and review of the literature. Molecular and Clinical Oncology 6 (5): 39–542.Google Scholar
- 7.Kadin, M.E., A. Deva, H. Xu, J. Morgan, P. Khare, R.A.F. MacLeod, B.W. van Natta, W.P. Adams Jr., G.S. Brody, and A.L. Epstein. 2016. Biomarkers provide clues to early events in the pathogenesis of breast implant-associated anaplastic large cell lymphoma. Aesthetic Surgery Journal 36: 773–781.CrossRefGoogle Scholar
- 8.Hu, H., A. Jacombs, K. Vickery, S.L. Merten, D.G. Pennington, and A.K. Deva. 2015. Chronic biofilm infection in breast implants is associated with an increased T-cell lymphocytic infiltrate: Implications for breast implant-associated lymphoma. Plastic and Reconstructive Surgery 135: 319–329.CrossRefGoogle Scholar
- 10.Headon, H., A. Kasem, and K. Mokbel. 2015. Capsular contracture after breast augmentation: An update for clinical practice. Plastic and Reconstructive Surgery Global Open 42: 532–543.Google Scholar
- 11.Loch-Wilkinson, A., K. Beath, R.J.W. Knight, W.L.F. Wessels, M. Magnusson, T. Papadopoulos, T. Connell, J. Lofts, M. Locke, I. Hopper, R. Cooter, K. Vickery, P.A. Joshi, H.M. Prince, and A.K. Deva. 2017. Breast implant associated anaplastic large cell lymphoma in Australia and New Zealand—High surface area textured implants are associated with increased risk. Plastic and Reconstructive Surgery Global Open 140: 645–654.CrossRefGoogle Scholar
- 12.U.S. Food and Drug Administration Center for Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/BreastImplants/ucm239995.htm. Accessed 10 Jan 2018.
- 14.Kyurkchiev, D., I. Bochev, E. Ivanova-Todorova, M. Mourdjeva, T. Oreshkova, K. Belemezova, and S. Kyurkchiev. 2014. Secretion of immunoregulatory cytokines by mesenchymal stem cells. Plastic and Reconstructive Surgery Global Open 6: 552–570.Google Scholar
- 17.Sasser, A.K., B.L. Mundy, K.M. Smith, A.W. Studebaker, A.E. Axel, A.M. Haidet, S.A. Fernandez, and B.M. Hall. 2007. Human bone marrow stromal cells enhance breast cancer cell growth rates in a cell line-dependent manner when evaluated in 3D tumor environments. Cancer Lett 254:255–264.Google Scholar
- 20.Orciani, M., R. Lazzarini, M. Scartozzi, E. Bolletta, M. Mattioli-Belmonte, A. Scalise, G. di Benedetto, and R. di Primio. 2013. The response of breast cancer cells to mesenchymal stem cells: A possible role of inflammation by breast implants. Plastic and Reconstructive Surgery 132: 899e–910e.CrossRefGoogle Scholar
- 27.U.S. Food and Drug Administration Center for Devices and Radiological Health. 2011. FDA medical device safety communication: Reports of anaplastic large cell lymphoma (ALCL) in women with breast implants. http://wayback.archive-it.org/7993/20170722214256/https://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm240000.htm. Accessed 10 Jan 2018.
- 28.Johnson, L., J.M. O'Donoghue, N. McLean, P. Turton, A.A. Khan, S.D. Turner, A. Lennard, N. Collis, M. Butterworth, G. Gui, J. Bristol, J. Hurren, S. Smith, K. Grover, G. Spyrou, K. Krupa, I.A. Azmy, I.E. Young, J.J. Staiano, H. Khalil, and F.A. MacNeill. 2017. Breast implant associated anaplastic large cell lymphoma: The UK experience. Recommendations on its management and implications for informed consent. European Journal of Surgical Oncology 43: 1393–1401.CrossRefGoogle Scholar
- 38.Stevens, W.G., M.Y. Nahabedian, M.B. Calobrace, J.L. Harrington, P.J. Capizzi, R. Cohen, R.C. d’Incelli, and M. Beckstrand. 2013. Risk factor analysis for capsular contracture: A 5-year Sientra study analysis using round, smooth, and textured implants for breast augmentation. Plastic and Reconstructive Surgery 132: 1115–1123.CrossRefGoogle Scholar
- 39.Boulland, M.L., V. Meignin, K. Leroy-Viard, C. Copie-Bergman, J. Brière, R. Touitou, P. Kanavaros, and P. Gaulard. 1998. Human interleukin-10 expression in T/natural killer-cell lymphomas association with anaplastic large cell lymphomas and nasal natural killer-cell lymphomas. The American Journal of Pathology 153: 1229–1237.CrossRefGoogle Scholar
- 40.Bianchi, A., S. Vallese, and O. Annibali. 2018. PD-L1/PD-1 check point in anaplastic large cell lymphoma, ALK+: A case report with Immunohistochemical and molecular study. Plastic and Reconstructive Surgery Global Open 3: 1.Google Scholar